These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7037387)

  • 21. Delayed hypersensitivity and cell-mediated immunity. A survey of current insights into these responses of the body to antigens.
    Maddison SE
    Clin Pediatr (Phila); 1973 Sep; 12(9):529-37. PubMed ID: 4579892
    [No Abstract]   [Full Text] [Related]  

  • 22. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.
    Kniker WT; Anderson CT; McBryde JL; Roumiantzeff M; Lesourd B
    Ann Allergy; 1984 Feb; 52(2):75-82. PubMed ID: 6696298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune suppression as related to toxicology.
    Vos JG
    CRC Crit Rev Toxicol; 1977 May; 5(1):67-101. PubMed ID: 17515
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats.
    Thorn M; Hudson AW; Kreeger J; Kawabe TT; Bowman CJ; Collinge M
    J Immunotoxicol; 2015; 12(4):350-60. PubMed ID: 25412622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity of delayed-type hypersensitivity and graft-versus-host reaction in testing of immunomodulators.
    Sůla K
    Folia Biol (Praha); 1992; 38(1):31-9. PubMed ID: 1597252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chronic developmental lead exposure on cell-mediated immune functions.
    Faith RE; Luster MI; Kimmel CA
    Clin Exp Immunol; 1979 Mar; 35(3):413-20. PubMed ID: 455779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotoxicity assessment: screening and function studies.
    Vos JG
    Arch Toxicol Suppl; 1980; 4():95-108. PubMed ID: 7002113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of cyclosporin A on cell-mediated immunity.
    Thomson AW; Webster LM
    Clin Exp Immunol; 1988 Mar; 71(3):369-76. PubMed ID: 2968199
    [No Abstract]   [Full Text] [Related]  

  • 30. The delayed type hypersensitivity assay using protein and xenogeneic cell antigens.
    Dietert RR; Bunn TL; Lee JE
    Methods Mol Biol; 2010; 598():185-94. PubMed ID: 19967514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo assessment of immunotoxicity.
    Munson AE; Sanders VM; Douglas KA; Sain LE; Kauffmann BM; White KL
    Environ Health Perspect; 1982 Feb; 43():41-52. PubMed ID: 7060547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of the delayed-type hypersensitivity response to alloantigen by xyloglucans or oligogalacturonide does not correlate with the capacity to reject ultraviolet-induced skin tumors in mice.
    Strickland FM; Sun Y; Darvill A; Eberhard S; Pauly M; Albersheim P
    J Invest Dermatol; 2001 Jan; 116(1):62-8. PubMed ID: 11168799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of anti-immunoglobulin sera on migration inhibition mediated by human lymphocytes.
    Marsman AJ; van der Hart M
    Eur J Immunol; 1974 Apr; 4(4):235-40. PubMed ID: 4859298
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens.
    Lesourd BM; Winters WD; Kniker WT
    J Clin Lab Immunol; 1986 Apr; 19(4):187-92. PubMed ID: 3723589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays.
    De Moerloose PA; Frazer IH; Sewell WA; Collins EJ; Mackay IR
    Clin Exp Immunol; 1986 May; 64(2):285-94. PubMed ID: 3091300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of early vitamin A supplementation on cell-mediated immunity in infants younger than 6 mo.
    Rahman MM; Mahalanabis D; Alvarez JO; Wahed MA; Islam MA; Habte D
    Am J Clin Nutr; 1997 Jan; 65(1):144-8. PubMed ID: 8988926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Delayed hypersensitivity and immunity in tuberculosis.
    Lefford MJ
    Am Rev Respir Dis; 1975 Mar; 111(3):243-6. PubMed ID: 804285
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 39. Steering orally induced deviation of xenogeneic immunity with exogenous cytokines in rats fed porcine proteins.
    Bridle BW; Wilkie BN; Jevnikar AM; Mallard BA
    Transpl Immunol; 2009 Dec; 22(1-2):32-7. PubMed ID: 19748586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.